GLNBX | RSEBX | GLNBX / RSEBX | |
Total Expense Ratio | 2.10 | 1.45 | 145% |
Annual Report Gross Expense Ratio | 2.56 | 1.45 | 177% |
Fund Existence | 14 years | 11 years | - |
Gain YTD | 10.333 | 9.389 | 110% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 71.9M | 80.3B | 0% |
Annual Yield % from dividends | 0.00 | 0.23 | - |
Returns for 1 year | 7.89 | 9.79 | 81% |
Returns for 3 years | 21.07 | 20.18 | 104% |
Returns for 5 years | 10.11 | 12.50 | 81% |
Returns for 10 years | 44.97 | 44.85 | 100% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 67.81 | 0.63 | +0.93% |
Invesco Biotechnology & Genome ETF | |||
SZOXF | 7.01 | N/A | N/A |
Deutsche Bank AG (London Branch) | |||
TDTF | 24.14 | -0.03 | -0.12% |
FlexShares iBoxx 5Yr Target Dur TIPS ETF | |||
ITOT | 140.57 | -0.33 | -0.23% |
iShares Core S&P Total US Stock Mkt ETF | |||
KNGZ | 34.61 | -0.11 | -0.32% |
FirstTrust S&P500 DvrsDiv AristocratsETF |